Study: Having two copies of gene mutation linked to Alzheimer’s may cause onset
By
Kristen Fischer
May 07, 2024
A new study finds that possessing two copies of a specific gene mutation that’s common in Alzheimer’s disease may be the cause behind the disease in those people.
Clinical briefs for Friday, Feb. 18
By
Amy Novotney
Feb 18, 2022
CDC reforming COVID-19 guidance … Nearly three-quarters of the U.S. now estimated to be immune to omicron variant … Brain synapse destruction culprit behind Alzheimer’s cognitive decline … Treatment...
Alzheimer’s drug slows mental, functional decline in Eli Lilly trial
By
Alicia Lasek
Jan 12, 2021
Participants who took donanemab for 76 weeks showed 32% slower decline in thinking and daily function compared with those in a placebo group.
Cataract surgery improves mood, cognition, sleep in Alzheimer’s patients, research shows
Oct 26, 2011
People with mild forms of Alzheimer’s disease experienced improvement in sleep patterns, cognitive functioning and mood after undergoing vision-correcting cataract surgery, new research revealed.
Lawmakers should weigh costs associated with dementia when coordinating care for Medicare beneficiaries,...
By
McKnight's Staff
May 17, 2012
As policymakers seek to integrate care for dual eligibles, they need to consider the cost of treating beneficiaries with dementia, new data suggests.
Eli Lilly aims for dementia drug candidate’s approval in 2022; wants to ‘prioritize access’
By
Alicia Lasek
Aug 04, 2021
The Alzheimer’s disease-modifying drug donanemab is on track to be considered for full FDA approval by 2022, its developer said.
Scientists say they’ve zeroed in on a cause of Alzheimer’s
By
Alicia Lasek
Dec 03, 2021
Researchers from the University of California, Riverside say they have uncovered a reason why some people with plaques and tangles in their brains do not develop Alzheimer’s disease.
Want to ward off dementia? Follow Madonna’s lead
By
May 17, 2016
If you really want to help cut your risks of cognitive impairment and memory loss, it might be time to go outside your comfort zone and take a few tips from the Material Girl herself.
Drug that targets Alzheimer’s inflammation approved for trial by FDA
By
Alicia Lasek
Feb 09, 2021
An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.
Working across care settings to improve dementia care
By
Leann Reynolds
Apr 19, 2012
Assisted living facilities, with or without a specialized memory wing, have started teaming up with in-home care companies that offer professional caregivers highly skilled in dementia care.